Mirae Asset Global Etfs Holdings Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 90,043 shares of RVMD stock, worth $5.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
90,043
Previous 76,950
17.01%
Holding current value
$5.14 Million
Previous $2.99 Million
36.6%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
266Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$851 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$765 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$651 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$646 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$432 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...